Mikkel Andreassen

Denmark

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Collaborators (16)

Antongiulio Faggiano

Sapienza University of Rome

ITALY

View details

Pasi I Nevalainen

Tampere University Hospital

FINLAND

View details

Jesper Krogh

Head of Clinic for Pituitary Disorders

Zealand University Hospital Køge

DENMARK

View details

Dermot O’Toole

Trinity College Dublin

IRELAND

View details

Caroline Clausen

MD, PhD, Assoc. Prof.

Rigshospitalet

DENMARK

View details

Caroline Kistorp

Professor

Rigshospitalet

DENMARK

View details

Pernille Holmager

Copenhagen University Hospital

DENMARK

View details

Pia Jaatinen

University of Tampere

FINLAND

View details

Reeta Rintamäki

Kuopio University Hospital

FINLAND

View details

Simona Grozinsky-Glasberg

ISRAEL

View details

Camilla Schalin-Jäntti

University of Helsinki

FINLAND

View details

Jens Otto Lunde Jørgensen

Aarhus University Hospital

DENMARK

View details

Marianne S. Andersen

DENMARK

View details

René Horsleben Petersen

Københavns Universitet

DENMARK

View details

Seppo W. Langer

DENMARK

View details

Ansgar Heck

Oslo University Hospital

NORWAY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mikkel Andreassen

Research Interests

Contact this professor

Articles (14)

Screening and surveillance practices for Multiple Endocrine Neoplasia type 1‐related Neuroendocrine Tumours in European Neuroendocrine Tumor Society Centers of Excellence (ENETS CoE)—An ENETS MEN1 task force questionnaire study

Significance of Exogenous Estradiol on Plasma Cortisol and Salivary Cortisol During Adrenocorticotropic Hormone Stimulation in Women With Pituitary Insufficiency

Primary Aldosteronism: Clinical Characteristics of Patients with a Paradoxical Increase in P-Aldosterone in Response to Captopril Challenge Test

Acromegaly management in the Nordic countries: A Delphi consensus survey

Recurrence Rates and Patterns after Radical Resection of Lung Carcinoids

Impressive Response to TANDEM Peptide Receptor Radionuclide Therapy with 177Lu/225AcDOTA-LM3 Somatostatin Receptor Antagonist in a Patient with Therapy-Refractory, Rapidly Progressive Neuroendocrine Neoplasm of the Pancreas

Outlook for 615 Small Intestinal Neuroendocrine Tumor Patients: Recurrence Risk after Surgery and Disease-Specific Survival in Advanced Disease

Responses to Medical Treatment in 192 Patients with Pancreatic Neuroendocrine Neoplasms Referred to the Copenhagen Neuroendocrine Tumour Centre in 2000–2020

Semaglutide treatment of hypothalamic obesity – a real-life data study

Successful liver transplantation as rescue therapy in a patient with metastases from a vasoactive intestinal peptide producing neuroendocrine tumor

Effects of Peptide Receptor Radiotherapy in Patients with Advanced Paraganglioma and Pheochromocytoma: A Nation-Wide Cohort Study

Changes in acromegaly comorbidities, treatment, and outcome over three decades: a nationwide cohort study

Recurrence-Free Survival and Disease-Specific Survival in Patients with Pancreatic Neuroendocrine Neoplasms: A Single-Center Retrospective Study of 413 Patients

Prognostic value of contralateral suppression on kidney function after surgery in patients with primary aldosteronism.

Collaborators (16)

Antongiulio Faggiano

Pasi I Nevalainen

Jesper Krogh

Dermot O’Toole

Caroline Clausen

Caroline Kistorp

Pernille Holmager

Pia Jaatinen

Reeta Rintamäki

Simona Grozinsky-Glasberg

Camilla Schalin-Jäntti

Jens Otto Lunde Jørgensen

Marianne S. Andersen

René Horsleben Petersen

Seppo W. Langer

Ansgar Heck

Make your next move.